Corrigendum to: A preclinical model of patient-derived cerebrospinal fluid circulating tumor cells for experimental therapeutics in leptomeningeal disease from melanoma

Authors:

Published: 2022-07-29

DOI: 10.1093/neuonc/noac181

Source: Full article

---

Abstract

No abstract found.